Economic analysis of promotion of hepatitis B vaccinations among Vietnamese-American children and adolescents in Houston and Dallas

Pediatrics

Volumn 111, Issue 6 I, 2003, Pages 1289-1296

  Zhou, Fangjun ^a   Euler, Gary L ^a   McPhee, Stephen J ^b   Nguyen, Thoa ^b   Lam, Tram ^b   Wong, Ching ^b   Mock, Jeremiah ^b  

^a CENTERS FOR DIS CONTR AND PREV   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benefit cost analysis; Community mobilization; Cost effectiveness analysis; Hepatitis B vaccination; Media education; Vietnamese Americans

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ARTICLE; CHILD; COMMUNITY CARE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH EDUCATION; HEPATITIS B; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MASS MEDIUM; PRIORITY JOURNAL; UNITED STATES; VACCINATION; VIET NAM; ASIAN AMERICAN; CLINICAL TRIAL; ECONOMICS; ETHNOLOGY; EVALUATION; HEALTH PROMOTION; METHODOLOGY; MULTICENTER STUDY; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; PUBLIC RELATIONS; STATISTICS;

ADOLESCENT; ASIAN AMERICANS; CHILD; CHILD, PRESCHOOL; COMMUNITY-INSTITUTIONAL RELATIONS; COST-BENEFIT ANALYSIS; HEALTH PROMOTION; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; UNITED STATES; VACCINATION; VIETNAM;

EID: 0038243194     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.111.6.1289     Document Type: Article

References (44)

1. Robinson WS. Hepatitis B virus and hepatitis D virus. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases 4th ed. New York, NY: Churchill Livingstone; 1995:1406-1439
2. Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. New York, NY: Grune & Stratton; 1984:209-224
3. Centers for Disease Control and Prevention. Update: recommendations to prevent hepatitis B virus transmission - United States. MMWR Morb Mortal Wkly Rep. 995;44:574-575
4. Hurie M, Mast EE. Horizontal transmission of hepatitis B virus infection to United States-bom children of Hmong refugees. Pediatrics. 1992;89:269-273
5. Margolis HS, Coleman PJ, Brown RE, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA. 1995;274:1201-1208
6. Mahoney F. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev. 1999;12:351-366
7. Mahoney F, Smith N, Alter M, Margolis HS. Progress towards the elimination of hepatitis B virus transmission in the United States. Viral Hepatitis Rev. 1997;3:105-119
8. Margolis HS, Alter M, Hadler S. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis. 1991;1184-1192
9. Coleman P, McQuillan G, Moyer L, Lambert S, Margolis H. Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys. J Infect Dis. 1998;178:954-959
10. Nelson KR, Bui H, Samet JH. Screening in special populations: a "case study" of recent Vietnamese Immigrants. Am J Med. 1997;102:435-440
11. Klontz KC. A program to provide hepatitis B immunoprophylaxis to infants born to HbsAg-positive Asian and Pacific Islander women. West J Med. 1987;146:195-199
12. Mahoney FJ, Lawrence M, Scott C, Le Q, Lambert S, Farley TA. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana. Pediatrics. 1995;96:1113-1116
13. Tong MJ, Hwang S-J. Hepatitis B infection in Asian Americans. Gastroenterol Clin North Am. 1994;23:532-536
14. Centers for Disease Control and Prevention. Screening for hepatitis B infection among refugees arriving in the United States, 1979-91. MMWR Morb Mortal Wkly Rep. 1991;40:784-786
15. Advisory Committee for Immunization Practices. Recommendations for protection against viral hepatitis. MMWR Recomm Rep. 1990;39(RR-2):1-26
16. Miller BA, Kolonel LN, Bernstein L, et al, eds. Racial/Ethnic Patterns of Cancer in the United States: 1988-92. Bethesda, MD: National Cancer Institute; 1996. NIH Publ. No. 96-4104
17. Taylor VM, Jackson JC, Pineda M, et al. Hepatitis B knowledge among Vietnamese immigrants: implications for prevention of hepatocellular carcinoma. J Cancer Educ. 2000;15:51-55
18. Centers for Disease Control. Recommendation of the Immunization Practices Advisory Committee (ACIP): inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982;31:317-322, 327-328
19. Euler GL. The epidemiology of hepatitis B vaccination catch-up among AAPI children in the United States. Asian Am Pacific Isl J Health. 2001;9:154-161
20. Dueson RR, Brodovicz KG, Barker L, Zhou F, Euler GL. Economic analysis of a child vaccination project among Asian Americans in Philadelphia, Pa. Arch Pediatr Adolesc Med. 2001;155:909-914
21. Jenkins CNH, McPhee SJ, Wong C, Nguyen T, Euler GL. Hepatitis B immunization coverage among Vietnamese-American children 3-18 years old. Pediatrics. 2000; 106(6). Available at: www.pediatrics.org/cgi/content/full/106/6/e78
22. Jenkins CNH, Buu C, Berger W, Son DT. Liver carcinoma prevention among Asian Pacific Islanders: getting shots into arms. Cancer. 2001;91:252-256
23. McPhee SJ, Nguyen T, Euler G, et al. Successful promotion of hepatitis B vaccinations among Vietnamese-American children aged 3 to 18: results of a controlled trial. Pediatrics. 2003;111:1278-1288
24. Centers for Disease Control and Prevention. Hepatitis B vaccination coverage among Asian and Pacific Islander children - United States, 1998. MMWR Morb Mortal Wkly Rep. 2000;49:616-619
25. VACMAN. Available at: http://www.cdc.gov/nip/vacman. Accessed October 12, 2001
26. Fleming GV. Vaccine administration fee survey: child health care update. Elk Grove Village, IL: American Academy of Pediatrics; 1995:11-16
27. Deuson R, Hoekstra E, Sedjo R, et al. The Denver school-based adolescent hepatitis B vaccination program: a cost analysis with risk simulation. Am J Public Health. 1999;89:1722-1727
28. Andre F, Zuckerman A. Protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144-154
29. Goh KT, Kong K, Chan S. Comparison of the immune response of four different dosages of a yeast recombinant hepatitis B vaccine in Singapore children: a four year follow-up study. Bull World Health Organ. 1992;70:233-239
30. Greenberg DP, Vadheim CM, Marcy SM, et al. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at 2, 4, and 6 months of age. In: Program and abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1992; Anaheim, CA. Abstract 264
31. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect. 1986;13(Suppl A):39-45
32. Da Villa G, Piazza M, Iorio R, et al. A pilot model of vaccination against hepatitis B virus suitable for mass vaccination campaigns in hyperendemic areas. J Med Virol. 1992;36:274-278
33. Haddix AE, Teutsch SM, Shaffer PA, Dunet DO, eds. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York, NY: Oxford University Press; 1996
34. Gold M, Siegel J, Russell L, Weinstein M. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996
35. Brookman R, Koff RS, Shaffner W, Margolis HS. Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable. J Adolesc Health. 1995;17:208-233
36. Bureau of Census. Demographics. 2000. Available at: http://www.census.gov/population/www/index.html. Accessed December 27, 2001
37. Bureau of Labor Statistics. Average Hourly Earnings. Department of Labor. 2000. Available at: http://www.bls.gov/bls/wages.htm. Accessed December 27, 2001
38. The MEDSTAT Group I. Marketscan Database (1996). Ann Arbor, MI: The Medstat Group; 1998
39. Tengs T, Adams M, Pliskin J, Safran D. Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis. 1995;15:369-390
40. Stratton KR, Durch JS, Lawrence RS, eds. Vaccinesfor the 21st Century: A Tool for Decision-making [Proof copy]. Washington, DC: National Academy Press; 1999
41. Vaccine Safety Committee Institute of Medicine. Hepatitis B Vaccine. In: Stratton KR, Howe C, Johnston R Jr, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press; 1994:211-235
42. Fishbein M. Great expectations, or do we ask too much from community-level interventions? [Editorial] Am J Public Health. 1996;86:1075-1076
43. LeBaron CW, Chambliss J, Chaney M. The impact of interventions by a community-based organization on inner-city vaccination coverage Fulton County, Georgia 1992-1993. Arch Pediatr Adolesc Med. 1999;152:322-332
44. Wood D, Schuster M, Donald-Sherbourne C, Duan N, Mazel R, Halfon N. Reduced missed opportunity to vaccinate during child health visit: how effective are parent education and case management? Arch Pediatr Adolesc Med. 1996;152:238-243